Arch Dis.Child Fetal Neonatal Ed 1998;78(3):F185-F188
The American Association of Clinical Endocrinologists (AACE) highlights that GLP-1R receptor agonists with proven cardiovascular benefits, such as liraglutide, semaglutide, and dulaglutide, should be considered for T2DM patients at high risk for ASCVD [123]
Most side effects are manageable with proper preparation and technique
A good multivitamin helps cover common nutrient gaps that can happen when appetite is low, meals get smaller, or food variety drops
Gupta says more research and more oversight is badly needed, especially given how widely the products are being used outside the traditional medical system
Initially, these authors described a specialized cytoplasmic protrusion from the base of GLP-1 cells termed the neuropod 57